GO:0001602 pancreatic polypeptide receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001602 (pancreatic polypeptide receptor activity) is a molecular function defined as combining with pancreatic polypeptide (PP) to initiate a change in cell activity.
• The best-characterized protein carrying this activity is NPY4R (also known as PPYR1 or Y4 receptor), which binds PP with high affinity and is sensitive to sodium ions and agonist-binding stability.
• PP-fold peptide receptors, including the PP-preferring receptor, show distinct peptide-binding requirements that have been mapped by structure-activity studies.
• Naturally occurring human NPY4R variants have been functionally characterized in vitro, revealing altered receptor behavior that may affect physiology.
• PP-fold peptide receptors have been implicated in angiotensin II-induced renal vasoconstriction, linking this activity to cardiovascular and renal biology.
• Studying GO:0001602 benefits from CRISPR-based knockout, point-mutation, knock-in, and overexpression models combined with binding, signaling, and transcriptomic readouts.
Description
Pancreatic polypeptide receptor activity (GO:0001602) is a molecular function that mediates cellular responses to pancreatic polypeptide (PP), a member of the PP-fold family of peptides. This activity is defined by the specific binding of PP to a receptor, which then initiates intracellular signaling and changes cell behavior. The receptor best known to exhibit this activity is NPY4R (also called PPYR1 or the Y4 receptor), a G protein-coupled receptor that preferentially binds PP and shows characteristic sodium sensitivity and agonist-binding stability. Understanding GO:0001602 is important because PP-fold peptides and their receptors regulate diverse physiological processes, and their dysfunction has been linked to metabolic, renal, and cardiovascular phenotypes. Researchers studying this term need reliable models to dissect receptor-ligand interactions, downstream signaling, and the impact of natural genetic variation.
pancreatic polypeptide receptor activity At A Glance
| GO ID | GO:0001602 |
|---|---|
| GO term | pancreatic polypeptide receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding pancreatic polypeptide (PP) to initiate a change in cell activity |
| Primary receptor | NPY4R (PPYR1, Y4 receptor) |
| Ligand | Pancreatic polypeptide (PP) |
| Related peptides | Peptide YY (PYY), neuropeptide Y (NPY), avian pancreatic polypeptide (aPP) |
| Ion sensitivity | Sodium-sensitive agonist binding reported for PP receptors |
| Tissue context | Expressed in brain and peripheral tissues; studied in vas deferens and kidney models |
What Is GO:0001602?
GO:0001602, pancreatic polypeptide receptor activity, is the molecular function of a receptor that binds pancreatic polypeptide (PP) and, upon binding, triggers a change in the activity of the cell. This activity is typically associated with G protein-coupled receptors of the PP-fold peptide receptor family, which recognize PP with specific affinity and couple to intracellular signaling pathways.
Why Is pancreatic polypeptide receptor activity Important in Cell Biology?
Pancreatic polypeptide receptor activity is important because it translates the presence of PP into cellular responses that influence energy balance, gastrointestinal function, and cardiovascular/renal physiology. The receptor's ability to discriminate among PP-fold peptides depends on precise structural features, and natural variants can alter this function, making it a relevant target for functional genomics and drug discovery.
• Defines a key molecular function for PP-fold peptide signaling in metabolic and neuroendocrine research.
• NPY4R is the prototypical receptor for this activity and is used to study ligand selectivity and receptor pharmacology.
• Sodium sensitivity and agonist-binding stability are distinctive features that affect experimental design.
• Natural human NPY4R variants can change receptor function, linking genotype to phenotype.
• PP-fold peptide receptors contribute to angiotensin II-induced renal vasoconstriction, connecting this activity to kidney physiology.
• Structure-activity studies provide a framework for understanding peptide binding requirements.
• The activity is relevant to comparative physiology, as PP receptors have been characterized in chicken and pig brains.
• Downstream signaling can involve dual G protein coupling, as shown for related pancreatic peptides in liver.
• CRISPR models enable causal testing of receptor variants and signaling nodes.
• The term supports research into peptide-based therapeutics and receptor-targeted interventions.
Molecular Mechanism of pancreatic polypeptide receptor activity
Ligand recognition and binding
In simple terms: The receptor first grabs onto pancreatic polypeptide like a lock accepting a key.
Pancreatic polypeptide receptor activity begins with the specific binding of PP to the receptor. The cloned human PP-preferring receptor shows distinct peptide binding requirements, and structure-activity analysis has defined which parts of PP-fold peptides are needed for high-affinity interaction. Binding is sensitive to sodium ions and the stability of agonist binding has been characterized for PP receptors.
Receptor selectivity among PP-fold peptides
In simple terms: The receptor can tell the difference between similar peptides, preferring PP over others.
The PP-preferring receptor discriminates among PP-fold peptides such as PP, PYY, and NPY. Studies on the cloned rat and human Y4 receptors revealed structure-activity relationships that explain why PP is the preferred ligand. Characterization of peptide binding requirements for the human PP-preferring receptor further defined the molecular determinants of selectivity.
Sodium sensitivity and binding stability
In simple terms: Salt levels can change how well the receptor holds onto its ligand.
PP receptors exhibit sodium sensitivity, and the stability of agonist binding is a measurable property of this activity. These features influence how receptor-ligand interactions are studied in vitro and may affect signaling outcomes in different ionic environments.
Natural variants and functional consequences
In simple terms: Some people carry slightly different versions of the receptor, which can work differently.
Twelve naturally occurring variants of the human pancreatic polypeptide receptor NPY4R have been functionally characterized in vitro, revealing that some variants alter receptor behavior. This highlights how genetic variation can modulate GO:0001602 activity and potentially contribute to phenotypic diversity.
Downstream signaling and cellular change
In simple terms: Once the receptor binds PP, it flips a switch inside the cell that changes what the cell does.
Binding of PP initiates a change in cell activity, which for related pancreatic peptides can involve dual coupling to different G proteins. PP-fold peptide receptors have been linked to angiotensin II-induced renal vasoconstriction, demonstrating that receptor activation can produce physiological effects in specific tissues.
Key Genes Involved in GO:0001602 pancreatic polypeptide receptor activity
The following genes and proteins are directly or functionally associated with pancreatic polypeptide receptor activity (GO:0001602) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPY4R (PPYR1) | Primary receptor for pancreatic polypeptide; carries GO:0001602 activity | Functional characterization of natural variants and ligand selectivity |
| PPY | Encodes pancreatic polypeptide, the endogenous ligand | Ligand used in binding and signaling assays |
| PYY | Encodes peptide YY, a related PP-fold peptide | Used to assess receptor selectivity |
| NPY | Encodes neuropeptide Y, a related PP-fold peptide | Comparator in structure-activity studies |
| GNAI1 | G protein alpha subunit potentially coupled to PP receptors | Downstream signaling studies for related pancreatic peptides |
| GNAQ | G protein alpha subunit potentially coupled to PP receptors | Dual G protein coupling context |
| AGTR1 | Angiotensin II receptor involved in renal vasoconstriction | Interaction with PP-fold peptide receptors in kidney |
| REN | Renin, part of the renin-angiotensin system | Physiological context for renal effects |
| ACE | Angiotensin-converting enzyme | Physiological context for renal effects |
| INS | Insulin, a metabolic hormone | Metabolic context of PP signaling |
| GCG | Glucagon, a metabolic hormone | Metabolic context of PP signaling |
| SST | Somatostatin, a regulatory peptide | Neuroendocrine context |
| POMC | Pro-opiomelanocortin, a neuropeptide precursor | Brain receptor characterization context |
| NPY1R | Related PP-fold peptide receptor | Comparative receptor pharmacology |
| NPY2R | Related PP-fold peptide receptor | Comparative receptor pharmacology |
| NPY5R | Related PP-fold peptide receptor | Comparative receptor pharmacology |
| GNAO1 | G protein alpha subunit potentially coupled to PP receptors | Downstream signaling context |
| GNAZ | G protein alpha subunit potentially coupled to PP receptors | Downstream signaling context |
How Is pancreatic polypeptide receptor activity Regulated?
The activity of pancreatic polypeptide receptors is regulated at multiple levels. Agonist binding is sensitive to sodium ions, and the stability of the agonist-receptor complex can influence signaling duration. Receptor selectivity among PP-fold peptides is determined by structural features of both ligand and receptor, as shown by structure-activity analyses. Natural genetic variants in NPY4R can alter receptor function, providing a layer of genetic regulation. Downstream, coupling to different G proteins can diversify signaling outcomes, as demonstrated for related pancreatic peptides in liver. Physiological contexts such as angiotensin II signaling can also modulate the functional impact of PP-fold peptide receptors in tissues like the kidney.
pancreatic polypeptide receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPY4R | Metabolic and neuroendocrine phenotypes | Knockout and point-mutation cell models |
| NPY4R | Renal vasoconstriction and blood pressure regulation | Knock-in of human variants in renal cells |
| AGTR1 | Angiotensin II-induced renal vasoconstriction | Co-culture signaling assays with PP receptor |
| PPY | Energy balance and gastrointestinal function | Overexpression and ligand-binding assays |
| GNAI1 | Downstream signaling in metabolic tissues | Knockout of G protein subunits in receptor-expressing cells |
Metabolic and neuroendocrine disorders
Pancreatic polypeptide and its receptors are part of the PP-fold peptide system that influences energy balance and neuroendocrine function. Functional characterization of NPY4R variants suggests that altered receptor activity could contribute to interindividual differences in metabolic phenotypes, although direct disease associations require further study.
Renal and cardiovascular biology
PP-fold peptide receptors have been implicated in angiotensin II-induced renal vasoconstriction, linking GO:0001602-related signaling to kidney function and blood pressure regulation. This connection suggests that pancreatic polypeptide receptor activity may be relevant to cardiovascular and renal pathophysiology.
Comparative and evolutionary physiology
Receptors for peptide-YY and avian pancreatic polypeptide have been characterized in chicken and pig brains, indicating that PP-fold peptide receptor activity is conserved across species and may inform translational studies.
From pancreatic polypeptide receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NPY4R mediate PP-induced signaling? | NPY4R knockout cell line |
| How do natural NPY4R variants alter function? | Point-mutation knock-in of variant alleles |
| Can PP receptor activity be tracked in live cells? | Tagged knock-in of NPY4R with fluorescent or luminescent tag |
| What is the effect of receptor overexpression? | Overexpression of NPY4R in naive cells |
| Which G proteins couple to PP receptors? | Knockout of specific G alpha subunits in receptor-expressing cells |
| What genes change downstream of PP receptor activation? | Transcriptomic profiling after PP stimulation in wild-type and mutant cells |
How to Study the pancreatic polypeptide receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Affinity and agonist stability | Receptor-ligand interaction studies |
| Sodium sensitivity assay | Ion-dependent binding changes | Characterization of PP receptor activity |
| Structure-activity analysis | Peptide determinants of binding | Selectivity profiling |
| Variant functional assay | Impact of natural mutations | NPY4R variant characterization |
| G protein coupling assay | Downstream signaling activation | Mechanistic studies |
| Renal vasoconstriction model | Physiological response | Cardiovascular/renal research |
| Comparative brain receptor assay | Species-specific binding | Evolutionary pharmacology |
Binding and signaling assays
Radioligand binding and agonist stability assays are used to measure pancreatic polypeptide receptor activity, including sodium sensitivity and affinity for PP-fold peptides. These methods help define ligand selectivity and receptor pharmacology.
Functional characterization of variants
In vitro functional characterization of naturally occurring NPY4R variants can reveal changes in receptor activity, such as altered binding or signaling. This approach links genotype to molecular function.
Comparative receptor pharmacology
Structure-activity studies using cloned receptors from different species, such as rat and human Y4 receptors, help identify conserved and divergent features of PP recognition. Characterization in chicken and pig brains further supports comparative analyses.
Downstream signaling and physiological readouts
Measurements of G protein coupling and physiological responses, such as renal vasoconstriction, provide context for how receptor activation translates into tissue-level effects. These readouts can be combined with genetic perturbation to establish causality.
How CRISPR Can Be Used to Study GO:0001602 pancreatic polypeptide receptor activity
Knockout
CRISPR knockout of NPY4R or related genes can eliminate pancreatic polypeptide receptor activity, allowing researchers to test whether observed signaling or physiological responses depend on this function. Knockout models are useful for validating receptor-specific effects in metabolic and renal assays.
Point Mutation
Point mutations can be introduced to mimic naturally occurring NPY4R variants or to probe residues required for ligand binding and sodium sensitivity. Such models help dissect structure-function relationships at the molecular level.
Knock-in
Knock-in of tagged or humanized receptor alleles enables tracking of receptor localization and function in relevant cell types. This approach can also be used to study species-specific differences in PP recognition.
Overexpression
Overexpression of NPY4R or its ligands can amplify signaling for biochemical and pharmacological assays, facilitating detection of downstream changes. Overexpression models are particularly useful when endogenous receptor levels are low.
How EDITGENE Supports pancreatic polypeptide receptor activity Research
Researchers studying pancreatic polypeptide receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for pancreatic polypeptide receptor activity research.
Frequently Asked Questions About pancreatic polypeptide receptor activity
What is pancreatic polypeptide receptor activity?
It is the molecular function defined by GO:0001602, where a receptor binds pancreatic polypeptide (PP) to initiate a change in cell activity.
What genes are involved in pancreatic polypeptide receptor activity?
The primary gene is NPY4R (also called PPYR1 or Y4 receptor), which encodes the receptor that binds PP with high affinity.
Which receptor binds pancreatic polypeptide?
NPY4R is the best-characterized receptor for pancreatic polypeptide, showing selectivity among PP-fold peptides.
How is pancreatic polypeptide receptor activity regulated?
It is regulated by ligand binding, sodium sensitivity, agonist-binding stability, genetic variants, and G protein coupling.
What diseases are linked to pancreatic polypeptide receptor activity?
It has been linked to metabolic and neuroendocrine phenotypes and to angiotensin II-induced renal vasoconstriction.
What methods are used to study pancreatic polypeptide receptor activity?
Radioligand binding, sodium sensitivity assays, structure-activity analysis, and functional characterization of variants are commonly used.
Are there natural variants of the pancreatic polypeptide receptor?
Yes, twelve naturally occurring variants of human NPY4R have been functionally characterized in vitro.
How does sodium affect pancreatic polypeptide receptor activity?
PP receptors exhibit sodium sensitivity, which can influence agonist binding and stability.
What G proteins couple to pancreatic polypeptide receptors?
Related pancreatic peptides can couple to different G proteins, and specific subunits such as GNAI1 and GNAQ may be involved.
Can CRISPR be used to study pancreatic polypeptide receptor activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of receptor function.
Conclusion
Pancreatic polypeptide receptor activity (GO:0001602) is a well-defined molecular function that mediates cellular responses to PP through specific receptor-ligand interactions. The receptor NPY4R is the primary protein carrying this activity, and its function is shaped by ligand selectivity, sodium sensitivity, natural genetic variation, and downstream G protein coupling. Studying this activity with CRISPR-based models and functional assays can clarify its roles in metabolism, renal physiology, and related diseases.
References
- 1. Shebanits K et al.. 2019. Functional characterization in vitro of twelve naturally occurring variants of the human pancreatic polypeptide receptor NPY4R.. Neuropeptides 76:101933 PMID: 31230758
- 2. Parker MS et al.. 2002. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding.. Peptides 23(2):291-303 PMID: 11825644
- 3. Walker MW et al.. 1997. A structure-activity analysis of the cloned rat and human Y4 receptors for pancreatic polypeptide.. Peptides 18(4):609-12 PMID: 9210181
- 4. Dubinion JH et al.. 2006. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.. Hypertension 47(3):545-51 PMID: 16365188
- 5. Gehlert DR et al.. 1996. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.. Mol Pharmacol 50(1):112-8 PMID: 8700103
- 6. Jørgensen JC et al.. 1990. Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.. Eur J Pharmacol 186(1):105-14 PMID: 2178092
- 7. Inui A et al.. 1990. Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.. Endocrinology 127(2):934-41 PMID: 2164925
- 8. Sánchez-Margalet V et al.. 1996. Pancreastatin action in the liver: dual coupling to different G proteins.. Cell Signal 8(1):9-12 PMID: 8777144
